These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 32548831)

  • 21. Molecular and muscle pathology in a series of caveolinopathy patients.
    Fulizio L; Nascimbeni AC; Fanin M; Piluso G; Politano L; Nigro V; Angelini C
    Hum Mutat; 2005 Jan; 25(1):82-9. PubMed ID: 15580566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and pathological changes result from mutated Caveolin-3 in muscle.
    González Coraspe JA; Weis J; Anderson ME; Münchberg U; Lorenz K; Buchkremer S; Carr S; Zahedi RP; Brauers E; Michels H; Sunada Y; Lochmüller H; Campbell KP; Freier E; Hathazi D; Roos A
    Skelet Muscle; 2018 Aug; 8(1):28. PubMed ID: 30153853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Getting rid of caveolins: phenotypes of caveolin-deficient animals.
    Le Lay S; Kurzchalia TV
    Biochim Biophys Acta; 2005 Dec; 1746(3):322-33. PubMed ID: 16019085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Caveolae-invaginations in the cell membrane with complex function. Defects in caveolae gene connected to severe congenital diseases].
    Swärd K; Uvelius B
    Lakartidningen; 2010 Jun 30-Jul 20; 107(26-28):1705-8. PubMed ID: 20701151
    [No Abstract]   [Full Text] [Related]  

  • 25. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease.
    Hnasko R; Lisanti MP
    Mol Interv; 2003 Dec; 3(8):445-64. PubMed ID: 14993453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Overview of Mitochondrial Protein Defects in Neuromuscular Diseases.
    Marra F; Lunetti P; Curcio R; Lasorsa FM; Capobianco L; Porcelli V; Dolce V; Fiermonte G; Scarcia P
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New techniques in the tissue diagnosis of gastrointestinal neuromuscular diseases.
    Knowles CH; Martin JE
    World J Gastroenterol; 2009 Jan; 15(2):192-7. PubMed ID: 19132769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunofluorescence-Based Analysis of Caveolin-3 in the Diagnostic Management of Neuromuscular Diseases.
    Roos A; Hathazi D; Schara U
    Methods Mol Biol; 2020; 2169():197-216. PubMed ID: 32548831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Role for Caveolin-3 in the Pathogenesis of Muscular Dystrophies.
    Pradhan BS; Prószyński TJ
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders.
    Gazzerro E; Bonetto A; Minetti C
    Handb Clin Neurol; 2011; 101():135-42. PubMed ID: 21496630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caveolinopathies: from the biology of caveolin-3 to human diseases.
    Gazzerro E; Sotgia F; Bruno C; Lisanti MP; Minetti C
    Eur J Hum Genet; 2010 Feb; 18(2):137-45. PubMed ID: 19584897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caveolae and caveolin-3 in muscular dystrophy.
    Galbiati F; Razani B; Lisanti MP
    Trends Mol Med; 2001 Oct; 7(10):435-41. PubMed ID: 11597517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases.
    Woodman SE; Sotgia F; Galbiati F; Minetti C; Lisanti MP
    Neurology; 2004 Feb; 62(4):538-43. PubMed ID: 14981167
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.